• 时尚资讯
  • 九块邮
  • 手机版
    • 最新折扣
    • 好券直播
    • 品牌券
    • 20封顶
    • 更多导航
      热门活动热门标签
    积分商城
    • 全部>“profile” 共888个商品
      • 默认
      • 销量
      • 价格
    • 预订 XENLETA (lefamulin acetate) Drug Profile, 2025: XENLETA (lefamulin acetate) drug patents, litigation, SPCs, clinica

      lefamulinXENLETAacetateDrug

      预订 XENLETA (lefamulin acetate) Drug Profile, 2025: XENLETA (lefamulin acetate) drug patents, litigation, SPCs, clinica

      ¥3,155券后¥3,3150人已购买
      优惠券¥160 领券购买 
    • 预订 VITRAKVI (larotrectinib sulfate) Drug Profile, 2025: VITRAKVI (larotrectinib sulfate) drug patents, SPCs, clinical

      larotrectinibVITRAKVIsulfateDrug

      预订 VITRAKVI (larotrectinib sulfate) Drug Profile, 2025: VITRAKVI (larotrectinib sulfate) drug patents, SPCs, clinical

      ¥3,172券后¥3,3320人已购买
      优惠券¥160 领券购买 
    • 预订 TAFINLAR (dabrafenib mesylate) Drug Profile, 2025: TAFINLAR (dabrafenib mesylate) drug patents, litigation, SPCs, c

      dabrafenibTAFINLARmesylateDrug

      预订 TAFINLAR (dabrafenib mesylate) Drug Profile, 2025: TAFINLAR (dabrafenib mesylate) drug patents, litigation, SPCs, c

      ¥3,182券后¥3,3420人已购买
      优惠券¥160 领券购买 
    • 预订 SYMBICORT (budesonide; formoterol fumarate dihydrate) Drug Profile, 2025: SYMBICORT (budesonide; formoterol fumarat

      budesonideformoterolSYMBICORTdihydrate

      预订 SYMBICORT (budesonide; formoterol fumarate dihydrate) Drug Profile, 2025: SYMBICORT (budesonide; formoterol fumarat

      ¥3,197券后¥3,3570人已购买
      优惠券¥160 领券购买 
    • 预订 Personality Profile and Induced Psychosis in Alcohol Dependence: 9783848494019

      9783848494019PersonalityDependencePsychosis

      预订 Personality Profile and Induced Psychosis in Alcohol Dependence: 9783848494019

      ¥950券后¥9840人已购买
      优惠券¥34 领券购买 
    • 预订 AUSTEDO XR (deutetrabenazine) Drug Profile, 2025: AUSTEDO XR (deutetrabenazine) drug patents, PTAB cases, clinical

      deutetrabenazineAUSTEDODrug预订

      预订 AUSTEDO XR (deutetrabenazine) Drug Profile, 2025: AUSTEDO XR (deutetrabenazine) drug patents, PTAB cases, clinical

      ¥3,150券后¥3,3100人已购买
      优惠券¥160 领券购买 
    • 预订 AUVELITY (bupropion hydrochloride; dextromethorphan hydrobromide) Drug Profile, 2025: AUVELITY (bupropion hydrochlo

      bupropionAUVELITYdextromethorphanhydrochloride

      预订 AUVELITY (bupropion hydrochloride; dextromethorphan hydrobromide) Drug Profile, 2025: AUVELITY (bupropion hydrochlo

      ¥3,199券后¥3,3590人已购买
      优惠券¥160 领券购买 
    • 预订 QBREXZA (glycopyrronium tosylate) Drug Profile, 2025: QBREXZA (glycopyrronium tosylate) drug patents, litigation, S

      glycopyrroniumtosylateQBREXZADrug

      预订 QBREXZA (glycopyrronium tosylate) Drug Profile, 2025: QBREXZA (glycopyrronium tosylate) drug patents, litigation, S

      ¥3,145券后¥3,3050人已购买
      优惠券¥160 领券购买 
    • 预订 SYNJARDY XR (empagliflozin; metformin hydrochloride) Drug Profile, 2025: SYNJARDY XR (empagliflozin; metformin hydr

      empagliflozinmetforminSYNJARDYhydrochloride

      预订 SYNJARDY XR (empagliflozin; metformin hydrochloride) Drug Profile, 2025: SYNJARDY XR (empagliflozin; metformin hydr

      ¥3,165券后¥3,3250人已购买
      优惠券¥160 领券购买 
    • 预订 BAXDELA (delafloxacin meglumine) Drug Profile, 2025: BAXDELA (delafloxacin meglumine) drug patents, litigation, SPC

      delafloxacinmeglumineBAXDELADrug

      预订 BAXDELA (delafloxacin meglumine) Drug Profile, 2025: BAXDELA (delafloxacin meglumine) drug patents, litigation, SPC

      ¥3,162券后¥3,3220人已购买
      优惠券¥160 领券购买 
    • 预订 BRENZAVVY (bexagliflozin) Drug Profile, 2025: BRENZAVVY (bexagliflozin) drug patents, litigation, suppliers, API so

      bexagliflozinBRENZAVVYDruglitigation

      预订 BRENZAVVY (bexagliflozin) Drug Profile, 2025: BRENZAVVY (bexagliflozin) drug patents, litigation, suppliers, API so

      ¥3,181券后¥3,3410人已购买
      优惠券¥160 领券购买 
    • 预订 APLENZIN (bupropion hydrobromide) Drug Profile, 2025: APLENZIN (bupropion hydrobromide) drug patents, patent challe

      hydrobromidebupropionAPLENZINDrug

      预订 APLENZIN (bupropion hydrobromide) Drug Profile, 2025: APLENZIN (bupropion hydrobromide) drug patents, patent challe

      ¥3,148券后¥3,3080人已购买
      优惠券¥160 领券购买 
    • 预订 DOVATO (dolutegravir sodium; lamivudine) Drug Profile, 2025: DOVATO (dolutegravir sodium; lamivudine) drug patents,

      dolutegravirlamivudineDOVATOsodium

      预订 DOVATO (dolutegravir sodium; lamivudine) Drug Profile, 2025: DOVATO (dolutegravir sodium; lamivudine) drug patents,

      ¥3,191券后¥3,3510人已购买
      优惠券¥160 领券购买 
    • 预订 VIBERZI (eluxadoline) Drug Profile, 2025: VIBERZI (eluxadoline) drug patents, litigation, SPCs, clinical trials, dr

      eluxadolineVIBERZIDruglitigation

      预订 VIBERZI (eluxadoline) Drug Profile, 2025: VIBERZI (eluxadoline) drug patents, litigation, SPCs, clinical trials, dr

      ¥3,171券后¥3,3310人已购买
      优惠券¥160 领券购买 
    • 预订 NUCYNTA ER (tapentadol hydrochloride) Drug Profile, 2025: NUCYNTA ER (tapentadol hydrochloride) drug patents, paten

      hydrochloridetapentadolNUCYNTADrug

      预订 NUCYNTA ER (tapentadol hydrochloride) Drug Profile, 2025: NUCYNTA ER (tapentadol hydrochloride) drug patents, paten

      ¥3,159券后¥3,3190人已购买
      优惠券¥160 领券购买 
    • 预订 DUOBRII (halobetasol propionate; tazarotene) Drug Profile, 2025: DUOBRII (halobetasol propionate; tazarotene) drug

      halobetasolpropionatetazaroteneDUOBRII

      预订 DUOBRII (halobetasol propionate; tazarotene) Drug Profile, 2025: DUOBRII (halobetasol propionate; tazarotene) drug

      ¥3,184券后¥3,3440人已购买
      优惠券¥160 领券购买 
    • 预订 SPINRAZA (nusinersen sodium) Drug Profile, 2025: SPINRAZA (nusinersen sodium) drug patents, SPCs, clinical trials,

      nusinersenSPINRAZAsodiumDrug

      预订 SPINRAZA (nusinersen sodium) Drug Profile, 2025: SPINRAZA (nusinersen sodium) drug patents, SPCs, clinical trials,

      ¥3,164券后¥3,3240人已购买
      优惠券¥160 领券购买 
    • 预订 A Victim Community: Stigma and the Media Legacy of High-Profile Crime: 9783030876814

      9783030876814Community预订Profile

      预订 A Victim Community: Stigma and the Media Legacy of High-Profile Crime: 9783030876814

      ¥1,817券后¥1,8970人已购买
      优惠券¥80 领券购买 
    • 海外直订A Profile of Jonathan Miller 乔纳森·米勒简介

      乔纳森米勒JonathanProfile

      海外直订A Profile of Jonathan Miller 乔纳森·米勒简介

      ¥1,278券后¥1,3780人已购买
      优惠券¥100 领券购买 
    • 预订【德语】 Schütteln Sie den Vasari ...:Kunsthistorische Profile

      德语Kunsthistorische预订Profile

      预订【德语】 Schütteln Sie den Vasari ...:Kunsthistorische Profile

      ¥270券后¥2760人已购买
      优惠券¥6 领券购买 
    • 预订 QINLOCK (ripretinib) Drug Profile, 2025: QINLOCK (ripretinib) drug patents, clinical trials, drug prices, suppliers

      ripretinibDrugQINLOCKsuppliers

      预订 QINLOCK (ripretinib) Drug Profile, 2025: QINLOCK (ripretinib) drug patents, clinical trials, drug prices, suppliers

      ¥3,152券后¥3,3120人已购买
      优惠券¥160 领券购买 
    • 预订 TAVALISSE (fostamatinib disodium) Drug Profile, 2025: TAVALISSE (fostamatinib disodium) drug patents, litigation, S

      fostamatinibTAVALISSEdisodiumDrug

      预订 TAVALISSE (fostamatinib disodium) Drug Profile, 2025: TAVALISSE (fostamatinib disodium) drug patents, litigation, S

      ¥3,161券后¥3,3210人已购买
      优惠券¥160 领券购买 
    • 预订 EVOTAZ (atazanavir sulfate; cobicistat) Drug Profile, 2025: EVOTAZ (atazanavir sulfate; cobicistat) drug patents, l

      atazanavircobicistatsulfateEVOTAZ

      预订 EVOTAZ (atazanavir sulfate; cobicistat) Drug Profile, 2025: EVOTAZ (atazanavir sulfate; cobicistat) drug patents, l

      ¥3,151券后¥3,3110人已购买
      优惠券¥160 领券购买 
    • 预订 ARISTADA (aripiprazole lauroxil) Drug Profile, 2025: ARISTADA (aripiprazole lauroxil) drug patents, litigation, SPC

      aripiprazoleARISTADAlauroxilDrug

      预订 ARISTADA (aripiprazole lauroxil) Drug Profile, 2025: ARISTADA (aripiprazole lauroxil) drug patents, litigation, SPC

      ¥3,153券后¥3,3130人已购买
      优惠券¥160 领券购买 
    • 预订 BRAFTOVI (encorafenib) Drug Profile, 2025: BRAFTOVI (encorafenib) drug patents, litigation, SPCs, clinical trials,

      encorafenibBRAFTOVIDruglitigation

      预订 BRAFTOVI (encorafenib) Drug Profile, 2025: BRAFTOVI (encorafenib) drug patents, litigation, SPCs, clinical trials,

      ¥3,206券后¥3,3660人已购买
      优惠券¥160 领券购买 
    • 预订 BELEODAQ (belinostat) Drug Profile, 2025: BELEODAQ (belinostat) drug patents, patent challenges, litigation, clinic

      belinostatBELEODAQDrugchallenges

      预订 BELEODAQ (belinostat) Drug Profile, 2025: BELEODAQ (belinostat) drug patents, patent challenges, litigation, clinic

      ¥3,159券后¥3,3190人已购买
      优惠券¥160 领券购买 
    • 预订 NINLARO (ixazomib citrate) Drug Profile, 2025: NINLARO (ixazomib citrate) drug patents, litigation, SPCs, clinical

      ixazomibNINLAROcitrateDrug

      预订 NINLARO (ixazomib citrate) Drug Profile, 2025: NINLARO (ixazomib citrate) drug patents, litigation, SPCs, clinical

      ¥3,176券后¥3,3360人已购买
      优惠券¥160 领券购买 
    • 预订 TAGRISSO (osimertinib mesylate) Drug Profile, 2025: TAGRISSO (osimertinib mesylate) drug patents, litigation, SPCs,

      osimertinibTAGRISSOmesylateDrug

      预订 TAGRISSO (osimertinib mesylate) Drug Profile, 2025: TAGRISSO (osimertinib mesylate) drug patents, litigation, SPCs,

      ¥3,182券后¥3,3420人已购买
      优惠券¥160 领券购买 
    • 预订 DUETACT (glimepiride; pioglitazone hydrochloride) Drug Profile, 2025: DUETACT (glimepiride; pioglitazone hydrochlor

      pioglitazoneglimepirideDUETACThydrochloride

      预订 DUETACT (glimepiride; pioglitazone hydrochloride) Drug Profile, 2025: DUETACT (glimepiride; pioglitazone hydrochlor

      ¥3,182券后¥3,3420人已购买
      优惠券¥160 领券购买 
    • 预订 Charting Your Health and Personal Health Profile: Be in Control of Your Health: 9781515356318

      HealthYour9781515356318预订

      预订 Charting Your Health and Personal Health Profile: Be in Control of Your Health: 9781515356318

      ¥179券后¥1840人已购买
      优惠券¥5 领券购买 
    • [预订]Music in Profile 9780197565407

      9780197565407预订ProfileMusic

      [预订]Music in Profile 9780197565407

      ¥308券后¥3420人已购买
      优惠券¥34 领券购买 
    • 【预售】Jan Welters: 轮廓英文摄影摄影师专辑进口原版外版书精装14岁以上Jan Welters: Profile Iain R. Webb Damiani

      外版书Welters英文R.

      【预售】Jan Welters: 轮廓英文摄影摄影师专辑进口原版外版书精装14岁以上Jan Welters: Profile Iain R. Webb Damiani

      ¥305.5券后¥318.30人已购买
      优惠券¥12.73 领券购买 
    • 预订 ADASUVE (loxapine) Drug Profile, 2025: ADASUVE (loxapine) drug patents, litigation, SPCs, clinical trials, drug pri

      loxapineDrugADASUVElitigation

      预订 ADASUVE (loxapine) Drug Profile, 2025: ADASUVE (loxapine) drug patents, litigation, SPCs, clinical trials, drug pri

      ¥3,151券后¥3,3110人已购买
      优惠券¥160 领券购买 
    • 预订 TIVICAY PD (dolutegravir sodium) Drug Profile, 2025: TIVICAY PD (dolutegravir sodium) drug patents, litigation, SPC

      dolutegravirTIVICAYsodiumDrug

      预订 TIVICAY PD (dolutegravir sodium) Drug Profile, 2025: TIVICAY PD (dolutegravir sodium) drug patents, litigation, SPC

      ¥3,184券后¥3,3440人已购买
      优惠券¥160 领券购买 
    • 预订 NEXPLANON (etonogestrel) Drug Profile, 2025: NEXPLANON (etonogestrel) drug patents, litigation, SPCs, clinical tria

      etonogestrelNEXPLANONDruglitigation

      预订 NEXPLANON (etonogestrel) Drug Profile, 2025: NEXPLANON (etonogestrel) drug patents, litigation, SPCs, clinical tria

      ¥3,154券后¥3,3140人已购买
      优惠券¥160 领券购买 
    • 海外直订The Making of Medieval Rome: A New Profile of the City, 400 - 1420 中世纪罗马的形成:城市的新面貌,400 - 142

      罗马中世纪面貌400

      海外直订The Making of Medieval Rome: A New Profile of the City, 400 - 1420 中世纪罗马的形成:城市的新面貌,400 - 142

      ¥647券后¥6970人已购买
      优惠券¥50 领券购买 
    • 预订 AMYVID (florbetapir f-18) Drug Profile, 2025: AMYVID (florbetapir f-18) drug patents, SPCs, clinical trials, suppli

      florbetapirAMYVIDDrug预订

      预订 AMYVID (florbetapir f-18) Drug Profile, 2025: AMYVID (florbetapir f-18) drug patents, SPCs, clinical trials, suppli

      ¥3,150券后¥3,3100人已购买
      优惠券¥160 领券购买 
    • 预订 COMETRIQ (cabozantinib s-malate) Drug Profile, 2025: COMETRIQ (cabozantinib s-malate) drug patents, litigation, PTA

      cabozantinibCOMETRIQmalateDrug

      预订 COMETRIQ (cabozantinib s-malate) Drug Profile, 2025: COMETRIQ (cabozantinib s-malate) drug patents, litigation, PTA

      ¥3,206券后¥3,3660人已购买
      优惠券¥160 领券购买 
    • 预订 NUBEQA (darolutamide) Drug Profile, 2025: NUBEQA (darolutamide) drug patents, SPCs, clinical trials, drug prices, s

      darolutamideDrugNUBEQA预订

      预订 NUBEQA (darolutamide) Drug Profile, 2025: NUBEQA (darolutamide) drug patents, SPCs, clinical trials, drug prices, s

      ¥3,155券后¥3,3150人已购买
      优惠券¥160 领券购买 
    • 预订 STIVARGA (regorafenib) Drug Profile, 2025: STIVARGA (regorafenib) drug patents, patent challenges, litigation, PTAB

      regorafenibSTIVARGADrugchallenges

      预订 STIVARGA (regorafenib) Drug Profile, 2025: STIVARGA (regorafenib) drug patents, patent challenges, litigation, PTAB

      ¥3,205券后¥3,3650人已购买
      优惠券¥160 领券购买 
    上一页 1 ...  17   18  19  20   21  ... 23 下一页